New York state lawmakers agree to legalise recreational cannabis
After several failed attempts to legalise the drug, it now appears recreational use will finally get the green light.
New York state moves closer to legalising recreational cannabis
Officials said they hoped the proposed new law would end the disproportionate policing of minority groups for low-level marijuana offences.
Scotland’s first cannabis clinic to open after regulators give green light
Regulators have approved Scotland’s first medicinal cannabis clinic.
Cannabis and cannabinoids in cancer pain management
An increasing number of patients are turning to cannabis and cannabinoids for management of their palliative and nonpalliative cancer pain and other cancer-related symptoms.
Medical Cannabis for Older Patients
Interest in the medicinal use of cannabis and cannabinoids is mounting worldwide. Fueled by enthusiastic media coverage, patients perceive cannabinoids as a natural remedy for many symptoms.
Anesthetic considerations in medical cannabis patients
Growing numbers of patients, consuming cannabinoids admitted to surgery, create a challenge to anesthesia providers.
Seth Rogen launched a weed brand, and the site immediately crashed
Seth Rogen announced the launch of his cannabis brand and the internet loved it so much, the site immediately went down. The actor/filmmaker/stoner and his longtime creative partner, Evan Goldberg, announced the launch of their cannabis company Houseplant on Monday. The name combines the brand’s two main products: “House” goods like ceramic ashtrays and lighters,…
Medical cannabis in the UK and the industry’s future
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry
A selective review of medical cannabis in cancer pain management
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
Medical cannabis in supportive cancer care: lessons from Canada
Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments.